Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors.

Several treatment-associated symptoms and functioning detriments were found 5-15 years after diagnosis. The results emphasize the need of a comprehensive, individualized survivorship care, recognizing differential needs of long-term BC survivors according to age, treatment modalities, and disease status.